(NYSEMKT: AZTR) Azitra's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.01%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.56%.
Azitra's earnings in 2026 is -$12,272,932.On average, 4 Wall Street analysts forecast AZTR's earnings for 2026 to be -$1,081,777, with the lowest AZTR earnings forecast at -$1,603,575, and the highest AZTR earnings forecast at -$509,071. On average, 4 Wall Street analysts forecast AZTR's earnings for 2027 to be -$19,781,061, with the lowest AZTR earnings forecast at -$32,665,416, and the highest AZTR earnings forecast at -$5,727,053.
In 2027, AZTR is forecast to generate -$649,066 in earnings, with the lowest earnings forecast at -$772,092 and the highest earnings forecast at -$509,071.